About the Event


Antimicrobial resistance, or AMR, is one of the most pressing public health challenges today, threatening progress on everything from the Sustainable Development Goals to the aspiration of delivering universal health coverage by 2030.

Every year, AMR is directly responsible for 1.27 million global deaths and contributes to another 5 million deaths, according to the World Health Organization. In 2019, sub-Saharan Africa experienced the highest number of AMR-attributed deaths and without urgent action, the region is expected to bear the highest burden of the predicted 10 million annual deaths by 2050.

In the lead-up to the U.N. General Assembly High-Level Meeting on antimicrobial resistance, this event, hosted by Devex in partnership with GSK and Amref Health Africa, will explore challenges and barriers, and spotlight how local solutions can be scaled through multistakeholder partnerships in order to build the capacity and awareness needed to effectively respond to the AMR challenge on the African continent, including through a regional action group.

Discussions will also highlight how a One Health approach can help countries effectively respond to the AMR challenge by holistically addressing human, animal, and environmental health within the implementation of their national action plans.

Register now to join us in person in New York or online for the live broadcast.

Hosted by:

Devex

In partnership with:


GSK

Agenda

Sept. 24
  • 1 p.m.
    ET

    Registration

  • 1:30 p.m.
    ET

    Opening remarks

    Richard Jones

    Editorial Director, Devex


    • 1:35 p.m.
      ET

      Fireside chat: Stepping up to the challenge: Scaling up local solutions to AMR

      Fiona Smith-Laittan

      Vice president - global health, GSK

      Dr. Yewande Alimi

      One Health Unit Lead, Africa CDC

      Interviewed by Alexandre Cabaret

      Vice President - Partnerships, Devex


    • 1:50 p.m.
      ET

      Panel: Addressing the threat of AMR through local solutions

      Vivian Nabisere

      Head of the Research Thematic group, and FAMSA representative, African Youth Antimicrobial Resistance Alliance Taskforce

      Margaret Odera

      Community health promoter, Ministry of Health, Kenya

      Prof. Mirfin Mpundu

      Senior antimicrobial resistance and biodefense adviser, USAID

      Interviewed by Rumbi Chakamba

      Associate Editor, Devex


    • 2:20 p.m.
      ET

      Wrap-up and call to action

      Dr. Githinji Gitahi

      CEO, Amref Health Africa


    • 2:30 p.m
      ET

      Closing remarks

      Richard Jones

      Editorial Director, Devex



Speakers:

Dr. Yewande Alimi

Dr. Yewande Alimi

One Health Unit Lead, Africa CDC

Dr. Githinji Gitahi

Dr. Githinji Gitahi

CEO, Amref Health Africa

Prof. Mirfin Mpundu

Prof. Mirfin Mpundu

Senior antimicrobial resistance and biodefense adviser, USAID

Vivian Nabisere

Vivian Nabisere

Head of the Research Thematic group, and FAMSA representative, African Youth Antimicrobial Resistance Alliance Taskforce

Margaret Odera

Margaret Odera

Community health promoter, Ministry of Health, Kenya

Fiona Smith-Laittan

Fiona Smith-Laittan

Vice president - global health, GSK